Advances in Practical, Broad Coverage CFTR Testing with the AmplideX® PCR/CE CFTR Kit

Advances in Practical, Broad Coverage CFTR Testing with the AmplideX® PCR/CE CFTR Kit

 

register here

 

Cystic fibrosis testing can be challenging for laboratories. Even though screening is recommended for all ethnicities, it can be difficult to provide reliable results for everyone, since most CFTR assays were designed based on outdated, ethnically-homogeneous data. Additionally, some assay workflows can be time-consuming, cost-prohibitive, or cumbersome for labs to use.

In this event, Asuragen is pleased to unveil the AmplideX® PCR/CE CFTR Kit*, which is designed to provide the broadest coverage** of the U.S. population of any available targeted kit, with an easy-to-implement workflow. Recent large-scale diverse datasets informed assay design to bridge coverage gaps left by other targeted assays, while the application of AmplideX technology streamlines the testing process.

Register now for access to:

  • Live webinars with C.E. credits and Q&A sessions
  • Presentations from knowledge experts in CFTR gene coverage variants
  • Detailed AmplideX PCR/CE CFTR Kit information
  • How to expand your lab menu with the AmplideX portfolio
  • The opportunity to chat with an AmplideX expert
  • For more information on the AmplideX PCR/CE CFTR Kit*, visit Asuragen.com/CFTR.

 

Practical CFTR Testing To Address Coverage Gaps with the AmplideX® PCR/CE CFTR Kit*

John N. Milligan, PhD
Senior Manager, Research & Development, Asuragen

 

 

Learn how recent large-scale diverse population studies provide a greater understanding of the diversity of CFTR variants and how this data has informed the AmplideX PCR/CE CFTR Kit* design to provide the broadest coverage** of any targeted CFTR testing kit.
________________________________________

Comprehensive Yet Streamlined Genetic Testing with
AmplideX® Technology

 

Ninad Pendsé, MBA
Senior Product Manager, Asuragen

 

This webinar will present the relevant genetic information needed in three common carrier screening genes (CFTR, SMN1/2, and FMR1), as well as how AmplideX assays provides this information with simple, complementary workflows made for real-world use.

_______________________________________

How Did They Do It? Real-World Lab Journeys to Genetic Test Implementation

Andrew Kincaid

 

Andrew Kincaid – Senior Manager, Field Applications, Asuragen

 

 

 

Tessa Gowan – Field Application Scientist, Asuragen

 

 

Stephanie Borel

 

Stephanie Borel, MS – Field Application Scientist, Asuragen

 

 

Le, Vivian

Vivian Le – Field Application Scientist, Asuragen

 

 

What does the process look like to implement a genetic assay in a molecular lab? What challenges need to be overcome and what support does Asuragen provide? This webinar will answer all those questions as our field application scientists present diverse real-world journeys of labs implementing AmplideX® genetic assays.

 

register here

________________________________________

*For Research Use Only. Not for use in diagnostic procedures.
**Based on Beauchamp KA, et al. Genet Med. 2019.

 

Back To
Top